Semiconductor fabless company Xcena has partnered with spatial omics-based techbio company Portrai to jointly develop large-scale biodata processing infrastructure based on CXL (Compute Express Link). As the scale of analysis data surges due to advances in spatial omics technology, this initiative seeks to overcome existing DRAM limitations through CXL memory expansion.

 

Xcena signed a Memorandum of Understanding (MOU) with Portrai on the 6th for establishing CXL-based biodata processing infrastructure and technical collaboration.

 

Key areas of collaboration under the agreement include: △verification of CXL memory expansion technology utilizing high-resolution spatial omics data and analysis pipelines held by Portrai △system configuration and optimization for large-scale spatial omics analysis △performance and scalability validation as data scale increases △promotion of application of Xcena's next-generation CXL memory solution 'MX1' △joint technology case studies and content development, etc.

Prior to signing the agreement, the two companies pre-validated 'ATERA', the spatial omics analysis workload from 10x Genomics used by Portrai, in the environment of Xcena's memory expansion solution 'InfiniteMemory®'.

 

Going forward, the two companies plan to expand the data scale to a maximum of 100 million cells to further validate the performance and scalability of CXL-based memory infrastructure.

 

Kim Jin-young, CEO of Xcena, stated, "We will continue to expand verification based on actual workloads and maintain cooperation through to the construction of commercial systems utilizing MX1."